Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.
about
Lysosomal storage diseases and the heat shock response: convergences and therapeutic opportunitiesRegulated necrotic cell death: the passive aggressive side of Bax and BakA hierarchical approach employing metabolic and gene expression profiles to identify the pathways that confer cytotoxicity in HepG2 cells.Identification of genes that regulate multiple cellular processes/responses in the context of lipotoxicity to hepatoma cells.A novel method incorporating gene ontology information for unsupervised clustering and feature selection.Emerging roles for lipids in non-apoptotic cell deathApplication of metabolic flux analysis to identify the mechanisms of free fatty acid toxicity to human hepatoma cell line.Heat shock protein 70 inhibits apoptosis in cancer cells through simultaneous and independent mechanismsHepatocyte death: a clear and present danger.The vascular contribution to Alzheimer's disease.The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicityApoptotic sphingolipid ceramide in cancer therapy.Apoptosis as a mechanism for liver disease progression.Renal lipid metabolism and lipotoxicity.An apoptosis panel for nonalcoholic steatohepatitis diagnosisGlucose and palmitate uncouple AMPK from autophagy in human aortic endothelial cellsEucommia ulmoides Oliver extract, aucubin, and geniposide enhance lysosomal activity to regulate ER stress and hepatic lipid accumulationEucommia ulmoides cortex, geniposide and aucubin regulate lipotoxicity through the inhibition of lysosomal BAX.Mechanisms of lipotoxicity in NAFLD and clinical implicationsHsp72 mediates TAp73α anti-apoptotic effects in small cell lung carcinoma cells.Cryptococcus neoformans-induced macrophage lysosome damage crucially contributes to fungal virulence.Diagnosis and evaluation of nonalcoholic fatty liver disease.Glycogen Synthase Kinase-3β and Caspase-2 Mediate Ceramide- and Etoposide-Induced Apoptosis by Regulating the Lysosomal-Mitochondrial Axis.Enhancing lysosome biogenesis attenuates BNIP3-induced cardiomyocyte deathToyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.Adipocyte hypertrophy is associated with lysosomal permeability both in vivo and in vitro: role in adipose tissue inflammationMyristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases.Qushi Huayu Decoction Inhibits Hepatic Lipid Accumulation by Activating AMP-Activated Protein Kinase In Vivo and In Vitro.Lysosomal cysteine cathepsins: signaling pathways in apoptosis.Translocation of iron from lysosomes into mitochondria is a key event during oxidative stress-induced hepatocellular injury.Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients.Repression of PKR mediates palmitate-induced apoptosis in HepG2 cells through regulation of Bcl-2.Lysosomal serine protease CLN2 regulates tumor necrosis factor-alpha-mediated apoptosis in a Bid-dependent mannerMolecular mechanisms of lipotoxicity in nonalcoholic fatty liver diseaseLipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equalRegulation of apoptosis-associated lysosomal membrane permeabilization.Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications.
P2860
Q27004531-C0E28BE0-2DA9-4F78-9100-D37E2AE2EEDCQ27021740-596BF71A-D122-45FE-902C-93FEA0AD3B34Q33284459-383E94D8-C215-4808-BBF7-B51CF32E3541Q33302071-0BBF418F-C0AB-4053-B050-76F62C97AA62Q33389178-F05FAB47-35B0-4C40-9FF5-CA5A5B2CD963Q33586741-12DAE7A4-134C-493D-BC22-D658FBA6C999Q33762092-E5E79E3A-5315-4A4F-BC80-E2EEDEA2DB51Q33958778-CAF7972A-E2A1-4FFD-BCD7-6C709CEE873BQ34147508-24517CC1-3DD5-457D-8903-29B61FE59F18Q34178526-E0B29116-D885-4D8C-BC74-1572E1279857Q34512981-30D5C878-4C49-4321-A9D9-0E407B719827Q34736760-87F2E431-E7AF-47F0-94C4-8C617E05BCB0Q34764471-8E273050-4141-4393-A532-FC18577CA7E5Q34825296-54C0A7A9-674D-4980-9DC8-8BDEFB42575DQ34995562-8479D4EC-933D-4ADF-8263-B1B11BB36729Q35034843-C7FC8EDE-E027-499B-8E5D-93C044736952Q35069547-7C45D686-B808-4ABA-97EA-BE90283CB8E3Q35106009-771E30AC-FAB9-4424-832F-EE0132E4913FQ35132916-A4D80F0E-D425-4D29-A1DC-33ED02895334Q35216158-1FBC872C-9FA9-4C2E-9730-9B801649C8A0Q35231374-BA6D059A-3595-41AF-90DD-AAE7670C5F32Q35495753-2F6ABA07-7CC1-41B8-8376-8EEEAAE3D38FQ35884004-BA520376-B6BE-4BCE-B238-EC9159205241Q35916125-2C7D1F6A-A162-43D3-823D-3F5E6EEA80A8Q36302806-A96BF5D9-6686-4D49-B755-1DEE05BC24A7Q36309443-ABB94C4B-3348-4BA0-8D70-6F77310A4A08Q36561524-0AE84867-B9C2-4F17-A97B-FB83052B1B13Q36572087-9498EFBF-73E4-44EE-ADE5-5C5240A17636Q36734149-1579E2D8-9502-4F2A-A95F-D4EB4EADF33DQ36841861-A1896B2E-1B3E-40D7-BF7C-95170710B14EQ36964130-3A537228-33B3-40E4-9AB7-420C47AE6BF8Q37051418-DC33E2A8-9874-4ED3-8C9F-F6857F8F6A80Q37062751-09D46053-4999-49C7-B7F1-F6951B496ED0Q37066731-B270A9B0-B627-4106-A001-A0343969132CQ37149001-D48E948F-5FE2-43A9-89AD-21BC7CE35B2DQ37160925-240CC0CF-9F33-4675-B9CE-4E10B163C8B6Q37310283-FC8B8B3D-1151-44CC-B2A4-95616294985FQ37578517-3CFCFA04-E740-4030-9A71-322938755434Q37676015-A35ABA5B-EB95-48F2-9D23-165A5F45D0A0Q37863133-3B543DB4-2CF2-451F-89C1-59995425A84B
P2860
Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.
@ast
Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.
@en
Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.
@nl
type
label
Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.
@ast
Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.
@en
Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.
@nl
prefLabel
Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.
@ast
Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.
@en
Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.
@nl
P2093
P2860
P356
P1476
Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.
@en
P2093
Ariel E Feldstein
Nathan W Werneburg
Steven F Bronk
Zhengzheng Li
P2860
P304
P356
10.1152/AJPGI.00509.2005
P577
2006-02-16T00:00:00Z